Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In vitro Mutagenesis01:16

In vitro Mutagenesis

5.5K
5.5K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

17.6K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.6K
Mutations01:39

Mutations

95.8K
Overview
95.8K
Mutations01:39

Mutations

13.6K
13.6K
Mutations01:35

Mutations

45.3K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.3K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

1.5K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HGVS Nomenclature 2024: improvements to community engagement, usability, and computability.

Genome medicine·2024
Same author

Author Correction: Standardizing variant naming in literature with VariantValidator to increase diagnostic rates.

Nature genetics·2024
Same author

Standardizing variant naming in literature with VariantValidator to increase diagnostic rates.

Nature genetics·2024
Same author

Comparison of the ABC and ACMG systems for variant classification.

European journal of human genetics : EJHG·2024
Same author

Systematic large-scale application of ClinGen InSiGHT <i>APC</i> -specific ACMG/AMP variant classification criteria substantially alleviates the burden of variants of uncertain significance in ClinVar and LOVD databases.

medRxiv : the preprint server for health sciences·2024
Same author

Hematologically important mutations: Leukocyte adhesion deficiency (second update).

Blood cells, molecules & diseases·2023

Related Experiment Video

Updated: Mar 18, 2026

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

11.3K

Sequence Variant Descriptions: HGVS Nomenclature and Mutalyzer.

Johan T den Dunnen1

  • 1Clinical Genetics & Human Genetics, Leiden University Medical Center, on behalf of the HGVS/HVP/HUGO Sequence Variant Description Working Group (SVD-WG), Leiden, The Netherlands.

Current Protocols in Human Genetics
|July 2, 2016
PubMed
Summary

Accurate description of genetic sequence variants is crucial for genomic analysis and diagnostics. The Human Genome Variation Society (HGVS) provides standardized nomenclature for describing DNA, RNA, and protein variations.

Keywords:
DNAdiagnosticsmutationnomenclaturesequencingstandardsvariant

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.7K
Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on: April 20, 2021

7.4K

Related Experiment Videos

Last Updated: Mar 18, 2026

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

11.3K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.7K
Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on: April 20, 2021

7.4K

Area of Science:

  • Genomics
  • Bioinformatics
  • Molecular Biology

Background:

  • Accurate description of genetic sequence variants is essential for genomic analysis and diagnostics.
  • The Human Genome Variation Society (HGVS) nomenclature is the international standard for variant description.

Purpose of the Study:

  • To describe the current HGVS nomenclature recommendations (version 15.11).
  • To provide guidance on describing variants at DNA, RNA, and protein levels.
  • To explain the rationale and provide examples for various variant types.

Main Methods:

  • Review and description of HGVS nomenclature version 15.11.
  • Explanation of variant description at DNA, RNA, and protein levels.
  • Inclusion of examples for various variant types and special cases.

Main Results:

  • Detailed explanation of HGVS nomenclature for substitutions, deletions, duplications, insertions, inversions, conversions, and complex variants.
  • Description of RNA-specific (splicing) and protein-specific (nonsense, frame shift, extension) variant types.
  • Introduction to support tools like the Mutalyzer suite for variant description.

Conclusions:

  • The HGVS nomenclature provides a standardized and unambiguous method for describing sequence variants.
  • Adherence to HGVS recommendations ensures consistency in reporting genomic variation data.
  • Available tools facilitate the correct application of HGVS nomenclature in research and diagnostics.